Plasma-Derived Therapeutics

CSL Behring

CSL Behring, the biotherapeutics arm of CSL Limited, is the world's largest manufacturer of plasma-derived and recombinant therapies for rare bleeding disorders, immune deficiencies, hereditary angioedema, and neurological conditions. Headquartered in King of Prussia, Pennsylvania, and with plasma fractionation facilities on five continents, CSL Behring operates the CSL Plasma donation network and maintains deep academic relationships with haemophilia treatment centres worldwide. The company's research infrastructure includes proteomic analysis of thousands of plasma donations, providing a uniquely rich data resource for scientists studying coagulation cascades, complement pathways, and albumin biology. CSL Behring funds academic chairs, doctoral studentships, and multi-centre clinical registries.